Study of malondialdehyde as an indicator of oxidative stress and its modulation by N-acetylcysteine in chronic obstructive pulmonary disease

Journal of Clinical and Diagnostic Research

Volumn 5, Issue 1, 2011, Pages 48-51

  Patil, Ameeta B ^a   Kale, Anita B ^b   Singhal, Sameer S ^b   Khan, Tanveer A ^b  

^a Padmashri Vikhe Patil College   (India)

^b DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chronic obstructive pulmonary disease; N acetylcysteine; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; MALONALDEHYDE; PLACEBO;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MUCOLYSIS; NAUSEA; OXIDATIVE STRESS; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; STOMATITIS; TREATMENT DURATION;

EID: 79952656773     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Arshad AB, Naveed NS, Rakesh B, Zuber A, Pandey DK, Khurshid AD, et al. Effect of oral N-acetylcysteine in COPD - A randomized controlled trial. JK-Practitioner. 2007; 14(1):12-16.
2. Premanand R, Santosh Kumar PH and Alladi M. Study of thiobarbituric reactive substances and total reduced glutathione as indices of oxidative stress in chronic smokers with and without chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci. 2007;49:9-12.
3. Evans WJ. Vitamin E, vitamin C and exercise. Am J Clin Nutr. 2000; 72:647S-652S.
4. John ER, Aalt B, Ida L. Oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1997; 156(2):341-357.
5. Dekhuijen PNR. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur Resp J. 2004; 23:629-636.
6. Nelstor AM. Drugs in clinical development for chronic obstructive pulmonary disease. Respiration 2005; 72:105-112.
7. Rando software. www.jipmer.edu. (Assessed on 14/05/2008). 123.
8. Hiroshi O, Nobuko O, and Kunio Y. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry. 1979;95:351-358.
9. Karageorgos N, Patsoukis N, Chroni E, Konstantinou D, Assimakopoulos SF, Georgiou C. Effect of N-acetylcysteine, allopurinol and vitamin E on jaundice-induced brain oxidative stress in rats. Brain Res. 2006; 21;1111(1):203-212.
10. Carlos TD, Darío M, Rogelio P, Majid E, Giovanni V. Biomass fuels and respiratory diseases. Am Thorac Soc. 2008; 5:577-590.
11. van Overveld FJ, Demkow U, Gorecka D, de Backer WA, Zielinski J. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysreine. J Physiol Pharmacol. 2005; 56 (4):135-142.
12. Phillippa JP, Peter NB. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 2001; 322:1271.
13. Zuin R, Palamidese A, Negrin R; Catozzo L, Scarda A, Balbinot M. High dose N-acetylcysteine in patients with exacerbations of chronic obstructive pulmonary disease. Clin Drug Invest. 2005; 25(6):401-408.
14. Borgstorm L, Kaged IB. Properties of N-acetylcysteine in man. Eur J Clin Pharmacol. 1986; 31:217-222.
15. Riise GC, Larsson S, Larsson P, Jeansson S, and Andersson BA. The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy. Eur. Respir. J 1994; 7:94-101.
16. Stey C et al. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Res J. 2000; 16:253-262.
17. Mant TG, Tempowski JH, Volans GN, Talbot JC. Adverse reactions to acetylcysteine and effects of overdose. Br Med J (Clin Res Ed) 1984;289:217-219.
18. Arstall MA, Yang J, Stafford I, Betts WH, Horowitz JD. N-acetylcysteine in combination with nitroglycerine and streptokinase for the treatment of evolving myocardial infarction. safety and biochemical effects. Circulation 1995; 92:2855-2862.
19. Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The disposition and kinetics of N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol. 1989; 37:501-506.